Literature DB >> 8738161

Up-regulation of cystatin C by microglia in the rat facial nucleus following axotomy.

T Miyake1, Y Gahara, M Nakayama, H Yamada, K Uwabe, T Kitamura.   

Abstract

Cystatin C, a cysteine proteinase inhibitor, is expressed in the central nervous system (CNS) as well as many other organs of mammals. However, little is known concerning whether its expression is regulated under pathological conditions of the CNS and what types of cells are responsible for this regulation. We performed differential hybridization screening of cDNA libraries derived from the rat facial nucleus and found a cDNA of rat cystatin C to be up-regulated following facial nerve axotomy. In situ hybridization using an RNA probe for rat cystatin C revealed that cystatin C mRNA in the facial nucleus was markedly increased in amount by day 7 after axotomy and was then decreased to the normal level by day 50. The intense signal for cystatin C mRNA in the damaged facial nucleus was localized in the glial cells which had the morphological characteristics of microglia. Light and electron microscopic immunohistochemistry using a rabbit antibody specific for cystatin C confirmed that microglia in the damaged facial nucleus were strongly positive for cystatin C. The immunoreactivity was also found in the extracellular space, consistent with the fact that cells producing cystatin C generally secrete this protein. These results demonstrate that cystatin C is markedly up-regulated by microglia in response to axotomy and is probably secreted by these cells into the extracellular space, suggesting that this proteinase inhibitor has (a) significant function(s) in the processes of neuronal degeneration, regeneration, and/or repair subsequent to axotomy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8738161     DOI: 10.1016/0169-328x(95)00337-r

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  7 in total

1.  Elevation of cystatin C in susceptible neurons in Alzheimer's disease.

Authors:  A Deng; M C Irizarry; R M Nitsch; J H Growdon; G W Rebeck
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 2.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

3.  The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases.

Authors:  Jan Mares; P Kanovsky; R Herzig; D Stejskal; J Vavrouskova; P Hlustik; H Vranova; S Burval; J Zapletalova; V Pidrman; R Obereigneru; A Suchy; J Vesely; J Podivinsky; K Urbanek
Journal:  Neurol Sci       Date:  2009-01-20       Impact factor: 3.307

Review 4.  Protective mechanisms by cystatin C in neurodegenerative diseases.

Authors:  Sebastien Gauthier; Gurjinder Kaur; Weiqian Mi; Belen Tizon; Efrat Levy
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01

5.  Cystatin C in Alzheimer's disease.

Authors:  Gurjinder Kaur; Efrat Levy
Journal:  Front Mol Neurosci       Date:  2012-07-06       Impact factor: 5.639

6.  Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis.

Authors:  Yu Zhu; Mi Yang; Fangjun Li; Menghua Li; Zhenzhen Xu; Fang Yang; Yue Liu; Wenzhi Chen; Yougen Zhang; Renshi Xu
Journal:  Int J Biol Sci       Date:  2018-06-03       Impact factor: 6.580

7.  Transcriptomic profiling of microglia and astrocytes throughout aging.

Authors:  Jie Pan; Nana Ma; Bo Yu; Wei Zhang; Jun Wan
Journal:  J Neuroinflammation       Date:  2020-04-01       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.